Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer [Phase 1, Phase 2]
Scancell's Modi-1 Moditope is being studied in Phase 1/2 trials across several cancers, including triple-negative breast cancer, renal cell …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer [Phase 2]
This document provides a Phase 2 clinical trial update on omitting local therapies in women with HER2-positive or triple-negative breast can…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC [Phase 3]
NordicTrip is a Phase 3 translational study evaluating preoperative chemotherapy for triple-negative breast cancer; the trial is currently a…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer [Phase 2]
This Phase 2 clinical trial compares nab-paclitaxel plus carboplatin versus nab-paclitaxel plus capecitabine in advanced triple-negative bre…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers [Phase 2]
A Phase 2 clinical trial update for SC-101 in nectin-4 amplified cancers, including triple-negative breast cancer and hormone receptor-posit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer [Phase 2]
A Phase 2 neoadjuvant breast cancer trial compares nab-paclitaxel plus carboplatin versus nab-paclitaxel plus epirubicin; the study is curre…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating camrelizumab with pirfenidone and chemotherapy for advanced triple-negative breast cancer; the study status is …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
A2 Biotherapeutics is evaluating A2B395, an allogeneic logic-gated CAR T therapy, in Phase 1/2 trials for solid tumors expressing EGFR and l…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers [Phase 1, Phase 2]
This clinical trial update describes the LOGIC study testing immune-modulation combined with cryoablation for triple-negative breast cancer,…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC [Phase 2]
Phase 2 trial update comparing Sacituzumab Govitecan plus Toripalimab versus Toripalimab plus Nab-Paclitaxel in PD-L1 positive advanced trip…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating alternating regimens of Sacituzumab govitecan and Trastuzumab deruxtecan in patients with metastatic …
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment [NA]
A clinical trial is evaluating the telemonitoring platform CUREETY TECHCARE versus standard of care for patients with metastatic triple-nega…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update focusing on preventing sacituzumab govitecan–related neutropenia in metastatic triple-negative breast cancer; the study…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer [Phase 3]
Phase 3 trial update exploring personalization of pembrolizumab use for patients with a strong early response in triple-negative breast canc…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel [Phase 2]
A Phase 2 study evaluating ceralasertib priming followed by durvalumab and nab-paclitaxel in metastatic triple-negative breast cancer; curre…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of sacituzumab govitecan plus anlotinib for metastatic triple-negative breast cance…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Comparison of the Breast Tumor Microenvironment
This document provides an update on a clinical trial studying the breast tumor microenvironment in breast cancer subtypes, including triple-…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy [Phase 2]
Phase 2 neoadjuvant breast cancer trial at Fudan University Shanghai Cancer Center evaluating a precision-platform therapy; the study is cur…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) [Phase 2]
Phase 2 trial ASPRIA is evaluating atezolizumab plus sacituzumab govitecan to prevent recurrence in triple-negative breast cancer, including…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating camrelizumab in combination with chemotherapy as neoadjuvant therapy for early or locally advanced tr…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-927 in combination with ABBV-368, Budigal…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]
Ongoing Phase 1/2 trial evaluating ProAgio in combination with Gemcitabine for metastatic triple-negative breast cancer, with patient recrui…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. [NA]
A clinical study evaluating the efficacy and safety of combining oral all-trans retinoic acid with toripalimab in triple-negative breast can…